Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CT
Antonios Tzortzakakis, Ove Gustafsson, Mattias Karlsson, et al.
EJNMMI Research (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review
Eduard Roussel, Umberto Capitanio, Alexander Kutikov, et al.
European Urology (2022) Vol. 81, Iss. 5, pp. 476-488
Open Access | Times Cited: 93
Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
Matteo Ferro, Gennaro Musi, Michele Marchioni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4615-4615
Open Access | Times Cited: 56
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
Octavian Sabin Tătaru, Michele Marchioni, Felice Crocetto, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 593-593
Open Access | Times Cited: 24
CT and MR imaging for solid renal mass characterization
Kohei Sasaguri, Naoki Takahashi
European Journal of Radiology (2017) Vol. 99, pp. 40-54
Closed Access | Times Cited: 87
Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis
Mitchell P. Wilson, Prayash Katlariwala, M. Hassan Murad, et al.
Abdominal Radiology (2020) Vol. 45, Iss. 8, pp. 2532-2541
Closed Access | Times Cited: 44
Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression
Steven P. Rowe, Michael A. Gorin, Lilja B. Sólnes, et al.
EJNMMI Research (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 43
ACR Appropriateness Criteria® Indeterminate Renal Mass
Zhen J. Wang, Paul Nikolaidis, Gaurav Khatri, et al.
Journal of the American College of Radiology (2020) Vol. 17, Iss. 11, pp. S415-S428
Open Access | Times Cited: 37
Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer
Francesco Trevisani, Matteo Floris, Roberto Minnei, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2603-2603
Open Access | Times Cited: 19
99mTc-sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide
Scott P. Campbell, Antonios Tzortzakakis, Mehrbod S. Javadi, et al.
British Journal of Radiology (2017) Vol. 91, Iss. 1084
Open Access | Times Cited: 30
Role of Virtual Biopsy in the Management of Renal Masses
Alberto Diaz de Leon, Matthew S. Davenport, Stuart G. Silverman, et al.
American Journal of Roentgenology (2019) Vol. 212, Iss. 6, pp. 1234-1243
Open Access | Times Cited: 27
Cost-effectiveness Analysis of 99mTc-sestamibi SPECT/CT to Guide Management of Small Renal Masses
Zhuo T. Su, Hiten D. Patel, Mitchell M. Huang, et al.
European Urology Focus (2020) Vol. 7, Iss. 4, pp. 827-834
Closed Access | Times Cited: 26
Diagnostic Accuracy of99mTc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses
Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 1, pp. 90-95
Open Access | Times Cited: 14
Renal Oncocytoma: An Algorithm for Diagnosis and Management
Maher Abdessater, Anthony Kanbar, Éva Compérat, et al.
Urology (2020) Vol. 143, pp. 173-180
Open Access | Times Cited: 23
The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?
Tariq Asi, Meltem Çağlar Tuncalı, Murat Tuncel, et al.
Urologic Oncology Seminars and Original Investigations (2020) Vol. 38, Iss. 12, pp. 937.e11-937.e17
Closed Access | Times Cited: 21
Deep learning with a convolutional neural network model to differentiate renal parenchymal tumors: a preliminary study
Yao Zheng, Shuai Wang, Yan Chen, et al.
Abdominal Radiology (2021) Vol. 46, Iss. 7, pp. 3260-3268
Closed Access | Times Cited: 20
Dual-Phase 99mTc-MIBI SPECT/CT in the Characterization of Enhancing Solid Renal Tumors
Hongjing Zhu, Bo Yang, Aisheng Dong, et al.
Clinical Nuclear Medicine (2020) Vol. 45, Iss. 10, pp. 765-770
Closed Access | Times Cited: 17
The value of 99mTc-sestamibi single-photon emission computed tomography-computed tomography in the evaluation and risk stratification of renal masses
Golmehr Sistani, Jennifer Bjazevic, Zahra Kassam, et al.
Canadian Urological Association Journal (2020) Vol. 15, Iss. 6
Open Access | Times Cited: 17
Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses
Krystyna M. Jones, Lilja B. Sólnes, Steven P. Rowe, et al.
Annals of Nuclear Medicine (2017) Vol. 32, Iss. 2, pp. 87-93
Closed Access | Times Cited: 17
Renal oncocytoma: landscape of diagnosis and management
Hannah Warren, Joana B. Neves, Maxine Tran
BJU International (2021) Vol. 128, Iss. 6, pp. 685-687
Open Access | Times Cited: 14
When More Is Better: Underused Advanced Imaging Exams That Can Improve Outcomes and Reduce Cost of Care
Ryan W. England, Sara Sheikhbahaei, Alex J. Solomon, et al.
The American Journal of Medicine (2021) Vol. 134, Iss. 7, pp. 848-853.e1
Closed Access | Times Cited: 12
Technetium‐99 m‐sestamibi single‐photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses
Pravin Viswambaram, Nicole Swarbrick, Alarick Picardo, et al.
BJU International (2022) Vol. 130, Iss. S3, pp. 23-31
Closed Access | Times Cited: 8
The role of molecular imaging in the characterization of renal masses
Alexa Meyer, Mohamad E. Allaf, Steven P. Rowe, et al.
Current Opinion in Urology (2018) Vol. 28, Iss. 2, pp. 159-165
Closed Access | Times Cited: 13
99mTc-sestamibi SPECT/CT—the jury is still out!
Hannah Warren, Maxine Tran
Translational Andrology and Urology (2024) Vol. 13, Iss. 6, pp. 1053-1055
Open Access | Times Cited: 1
Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality?
Steven P. Rowe, Mehrbod S. Javadi, Mohamad E. Allaf, et al.
EJNMMI Research (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 12
The evolving role of percutaneous biopsy in renal masses
Nathalie Garstka, Shahrokh F. Shariat, Mesut Remzi
Current Opinion in Urology (2018) Vol. 28, Iss. 4, pp. 364-368
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top